Altimmune Inc (NQ: ALT )
7.540
+1.050
(+16.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
All News about Altimmune Inc
![](https://mms.businesswire.com/media/20240510851848/en/805853/22/Robbins_LLP.jpg)
![](http://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
Via TheNewswire.com
Topics
Lawsuit
![](https://investorplace.com/wp-content/uploads/2022/07/alt-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Peering Into Altimmune's Recent Short Interest
April 30, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
How Is The Market Feeling About Altimmune?
April 08, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240510663235/en/478343/5/GPM_Logo_Colo.jpg)
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/biotech_bigpharma1600.png)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://mms.businesswire.com/media/20240508985177/en/478343/5/GPM_Logo_Colo.jpg)
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
![](https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240507308463/en/765953/22/Close_Up_Logo_HD_Blue.jpg)
![](https://mms.businesswire.com/media/20240507610734/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
![](https://ml.globenewswire.com/media/5d514042-8326-4555-8ad7-f6cc765ecfcd/small/bl-new-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/07/jim-cramer-chart-shutter.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/images/story/2024/04/29/Deutsche-Bank-Photo-by-1take1shot-on-Shu.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/biotech_bigpharma1600.png)
![](https://www.marketbeat.com/logos/articles/med_20240421190445_wegovy-vs.jpg)
![](https://g.foolcdn.com/editorial/images/772798/pharmacist-handing-prescription-medication-to-a-customer.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://g.foolcdn.com/editorial/images/771899/gettyimages-1429005115.jpg)
Via The Motley Fool
![](https://www.marketbeat.com/logos/articles/med_20240408193046_can-altimmune-get-its-glp-1-drug-to-market-before.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/03/28/image44.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.